A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 1,849 shares of CYTK stock, worth $79,691. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,849
Holding current value
$79,691
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$46.36 - $58.62 $85,719 - $108,388
1,849 New
1,849 $87 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $890,268 - $1.51 Million
13,965 New
13,965 $979 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.06B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.